AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+3.4%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.51B
AUM Growth
+$3.51B
(-15%)
Cap. Flow
-$436M
Cap. Flow
% of AUM
-12.4%
Top 10 Holdings %
Top 10 Hldgs %
30.68%
Holding
202
New
57
Increased
36
Reduced
24
Closed
61
Top Buys
| 1 |
Home Depot
HD
|
$105M |
| 2 |
PTC Therapeutics
PTCT
|
$79.1M |
| 3 |
Target
TGT
|
$68.3M |
| 4 |
Viatris
VTRS
|
$63.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
$60.9M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$67.8M |
| 2 |
Academy Sports + Outdoors
ASO
|
$66.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$65.8M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$63.2M |
| 5 |
Ulta Beauty
ULTA
|
$62.1M |
Sector Composition
| 1 | Healthcare | 66.72% |
| 2 | Consumer Staples | 13.57% |
| 3 | Consumer Discretionary | 10.09% |
| 4 | Technology | 5.16% |
| 5 | Communication Services | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Talphera
TLPH
$11.2M
| – | – |
-8,365,000
| Closed | -$4.69M |
|
202
Trevi Therapeutics
TRVI
$871M
| – | – |
-1,512,344
| Closed | -$1.18M |
|